Why screening for type 2 diabetes is necessary even in poor resource settings

Journal of Diabetes and its Complications

Volumn 29, Issue 7, 2015, Pages 961-964

  Unnikrishnan, Ranjit ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Complications; Cost effective; Resource constrained settings; Screening; Type 2 diabetes

Indexed keywords

ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING TEST; ADULT; AGED; COST BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; HEALTH CARE PLANNING; HEALTH SERVICE; INDIA; MALE; MASS SCREENING; MIDDLE AGED; POVERTY; PROCEDURES; SOCIOECONOMICS;

ADULT; AGED; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH RESOURCES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INDIA; MALE; MASS SCREENING; MIDDLE AGED; POVERTY; SOCIOECONOMIC FACTORS;

EID: 84939568851     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.05.011     Document Type: Review

References (34)

1. American Diabetes Association Standards of Medical Care in Diabetes - 2015: Summary of revisions Diabetes Care 38 Supplement 1 2015
2. R.M. Anjana, R. Pradeepa, M. Deepa, M. Datta, V. Sudha, R. Unnikrishnan, and et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study Diabetologia 54 2011 3022 3027
3. R.M. Anjana, C.S. Shanthirani, R. Unnikrishnan, P. Mugilan, A. Amutha, H.D. Nair, and et al. Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: A 9-year follow-up study Acta Diabetologica 52 2015 601 609
4. V.R. Aroda, and V.A. Fonseca U.S. Preventive Services Task Force criteria for diabetes screening: Time to revisit the evidence? American Journal of Preventive Medicine 45 2013 246 247
5. E.L. Barr, P.Z. Zimmet, T.A. Welborn, D. Jolley, D.J. Magliano, D.W. Dunstan, and et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation 116 2007 151 157
6. J.B. Brown, G.A. Nichols, and A. Perry The burden of treatment failure in type 2 diabetes Diabetes Care 27 2004 1535 1540
7. Canadian Task Force on Preventive Health Care, K. Pottie, A. Jaramillo, G. Lewin, J. Dickinson, N. Bell, and et al. Recommendations on screening for type 2 diabetes in adults CMAJ 184 2012 1687 1696
8. S.S. Casagrande, C.C. Cowie, and J.E. Fradkin Utility of the U.S. Preventive Services Task Force criteria for diabetes screening American Journal of Preventive Medicine 45 2013 167 174
9. P. Cavanagh, C. Attinger, Z. Abbas, A. Bal, N. Rojas, and Z.R. Xu Cost of treating diabetic foot ulcers in five different countries Diabetes Research and Clinical Practice 28 Suppl.1 2012 107 111
10. R. Chatterjee, K.M. Narayan, J. Lipscomb, S.L. Jackson, Q. Long, M. Zhu, and et al. Screening for diabetes and prediabetes should be cost-saving in patients at high risk Diabetes Care 36 2013 1981 1987
11. A.J. Garber, M.J. Abrahamson, J.I. Barzilay, L. Blonde, Z.T. Bloomgarden, M.A. Bush, and et al. AACE comprehensive diabetes management algorithm 2013 Endocrine Practice 19 2013 327 336
12. W.H. Herman, and R.C. Eastman The effects of treatment on the direct costs of diabetes Diabetes Care 21 Suppl. 3 1998 C19 C24
13. T.J. Hoerger, R. Harris, K.A. Hicks, K. Donahue, S. Sorensen, and M. Engelgau Screening for type 2 diabetes mellitus: A cost-effectiveness analysis Annals of Internal Medicine 140 2004 698 699
14. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A.W. Neil 10-Year follow-up of intensive glucose control in type 2 diabetes New England Journal of Medicine 359 2008 1577 1589
15. International Diabetes Federation IDF diabetes atlas 2013 International Diabetes Federation Brussels, Belgium Accessed at http://www.idf.org/diabetesatlas on 27.01.2014
16. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, and et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 35 2012 1364 1379
17. H.W. Kaufman, Z. Chen, V.A. Fonseca, and M.J. McPhaul Surge in newly identified diabetes among medicaid patients in 2014 within medicaid expansion States under the affordable care act Diabetes Care 38 2015 833 837
18. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, and et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin New England Journal of Medicine 346 2002 393 403
19. V. Mohan, R. Deepa, M. Deepa, S. Somannavar, and M. Datta A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects Journal of the Association of Physicians of India 53 2005 759 763
20. V. Mohan, M. Deepa, M. Pradeepa, V. Prathiba, M. Datta, S. Ravikumar, and et al. Prevention of diabetes in rural India with a telemedicine intervention Journal of Diabetes Science and Technology 6 2012 1355 1364
21. V. Mohan, R. Pradeepa, M. Deepa, R.M. Anjana, R. Unnikrishnan, and M. Datta How to detect the millions of people in India with undiagnosed diabetes cost effectively M.S. Rao, API Medicine Update 2010 Association of Physicians of India Mumbai 93 96
22. V. Mohan, V. Prathiba, and R. Pradeepa Tele-diabetology to screen for diabetes and associated complications in rural India: The Chunampet Rural Diabetes Prevention Project Model Journal of Diabetes Science and Technology 8 2014 256 261
23. D.M. Nathan, M.B. Davidson, R.A. DeFronzo, R.J. Heine, R.R. Henry, R. Pratley, and et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care Diabetes Care 30 2007 753 759
24. D. Noble, R. Mathur, T. Dent, C. Meads, and T. Greenhalgh Risk models and scores for type 2 diabetes: Systematic review BMJ 343 2011 d7163
25. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, and et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Research and Clinical Practice 28 1995 103 117
26. U.S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement Annals of Internal Medicine 148 2008 846 854
27. A. Ramachandran, C. Snehalatha, V. Vijay, N.J. Wareham, and S. Colagiuri Derivation and validation of diabetes risk score for urban Asian Indians Diabetes Research and Clinical Practice 70 2005 63 70
28. S. Somannavar, A. Ganesan, M. Deepa, M. Datta, and V. Mohan Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India Diabetes Care 32 2009 641 643
29. A.G. Tabák, C. Herder, W. Rathmann, E.J. Brunner, and M. Kivimäki Prediabetes: A high-risk state for diabetes development Lancet 379 2012 2279 2290
30. S. Tharkar, A. Devarajan, S. Kumpatla, and V. Viswanathan The socioeconomics of diabetes from a developing country: A population based cost of illness study Diabetes Research and Clinical Practice 89 2010 334 340
31. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes New England Journal of Medicine 358 2008 2545 2559
32. J. Tuomilehto, J. Lindström, J.G. Eriksson, T.T. Valle, H. Hämäläinen, P. Ilanne-Parikka, and et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance New England Journal of Medicine 344 2001 1343 1350
33. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
34. J.M.G. Wilson, and G. Jungner Principles and practice of screening for disease 1968 World Health Organization Geneva